Cargando…

Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis

BACKGROUND: The deeper understanding of the complex hereditary basis of familial hypercholesterolemia (FH) has raised the rationale of genetic testing, which has been underutilized in clinical practice. OBJECTIVES: The present study aimed to explore the variant spectrum of FH in an expanding manner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Ye-Xuan, Sun, Di, Liu, Hui-Hui, Jin, Jing-Lu, Li, Sha, Guo, Yuan-Lin, Wu, Na-Qiong, Zhu, Cheng-Gang, Liu, Geng, Dong, Qian, Sun, Jing, Chen, Xie-Hui, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627923/ https://www.ncbi.nlm.nih.gov/pubmed/36338372 http://dx.doi.org/10.1016/j.jacasi.2021.04.001

Ejemplares similares

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease
por: Cao, Ye-Xuan, et al.
Publicado: (2018)

A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia
por: Sun, Di, et al.
Publicado: (2019)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

The Ongoing Efforts Toward a Definite Diagnosis of Familial Hypercholesterolemia
por: Yu, Haojie
Publicado: (2021)

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
por: Sun, Di, et al.
Publicado: (2018)

Applications of machine learning in familial hypercholesterolemia
por: Luo, Ren-Fei, et al.
Publicado: (2023)

SORBS2 as a molecular target for atherosclerosis in patients with familial hypercholesterolemia
por: Liu, Ming-Ming, et al.
Publicado: (2022)

Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia
por: Wen, Jun, et al.
Publicado: (2019)

Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia
por: Okada, Hirofumi, et al.
Publicado: (2022)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction
por: Cao, Ye-Xuan, et al.
Publicado: (2022)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Molecular diagnosis methods in familial hypercholesterolemia
por: Moldovan, Valeriu, et al.
Publicado: (2020)

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
por: McGowan, Mary P., et al.
Publicado: (2019)

Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia
por: Wu, Wen-Feng, et al.
Publicado: (2014)

Gas Chromatography and Flame-Ionization Detection of Non-Cholesterol Sterols as Indicators of Cholesterol Absorption and Synthesis in 158 Chinese Individuals with Normolipidemia, Hyperlipidemia, and Familial Hypercholesterolemia
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia
por: Liu, Ming-Ming, et al.
Publicado: (2021)

The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition
por: Wang, Yan, et al.
Publicado: (2019)

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study
por: Liu, Hui-Hui, et al.
Publicado: (2019)

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2015)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
por: Cao, Ye-Xuan, et al.
Publicado: (2019)

Circulating Total Bilirubin and Long-Term Prognosis in Patients With Previous Myocardial Infarction
por: Cao, Ye-Xuan, et al.
Publicado: (2023)

Mutation detection in Chinese patients with familial hypercholesterolemia
por: Du, Ran, et al.
Publicado: (2016)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status
por: Jin, Jing-Lu, et al.
Publicado: (2019)

Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
por: Mytilinaiou, Maria, et al.
Publicado: (2018)

Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis
por: Di Taranto, Maria Donata, et al.
Publicado: (2023)

Impact of Familial Hypercholesterolemia Diagnosis in Real-World Data
por: Harada-Shiba, Mariko
Publicado: (2023)

Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
por: Shi, Hui-Wei, et al.
Publicado: (2020)

Collaboration between Family Physicians and Specialists in the Diagnosis and Management of Familial Hypercholesterolemia
por: Kotani, Kazuhiko
Publicado: (2021)

Case report: exome sequencing achieved a definite diagnosis in a Chinese family with muscle atrophy
por: Jiang, Hui, et al.
Publicado: (2021)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study
por: Zhang, Hui-Wen, et al.
Publicado: (2020)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcn1e3o2fb5ipvn2nhj82dskda